News
-
-
PRESS RELEASE
Information on the Annual Financial Statements 2025
Biophytis SA provides an update on the progress of finalizing the 2025 annual accounts and audit procedures, facing delays. The Company is actively working with its auditors to complete the process efficiently and comply with regulatory standards -
-
-
REGULATED PRESS RELEASE
BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Biophytis changes financing agreement with Hexagon Capital Fund, ensuring renewable €2 million facility, with revised terms enhancing financial flexibility and reducing interest rate -
REGULATED PRESS RELEASE
BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Biophytis modifie sa ligne de financement avec Hexagon Capital Fund pour rendre renouvelable sa capacite de tirage de 2M€. Les ajustements visent une optimisation financiere et une flexibilite accrue -
PRESS RELEASE
BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Biophytis modifie sa ligne de financement avec Hexagon Capital Fund pour rendre renouvelable sa capacité de tirage de 2M€, renforçant sa visibilité financière et sa flexibilité de financement -
PRESS RELEASE
BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Biophytis restructures financing agreement with Hexagon Capital Fund, making €2 million facility revolving and reducing interest rate from 12% to 10%, enhancing financial flexibility and visibility -
-
